Literature DB >> 29238932

Risk factors and clinical outcomes of hypervirulent Klebsiella pneumoniae induced bloodstream infections.

Jiayang Li1, Jianan Ren2, Weiping Wang3, Gefei Wang1, Guosheng Gu1, Xiuwen Wu1, Ying Wang4, Mei Huang4, Jieshou Li1.   

Abstract

The prevalence of hypervirulent Klebsiella pneumoniae (hvKP) is high in China, but clinical characteristics and outcomes of hvKP induced bloodstream infections (BSIs) are not clear. The purpose of the present study was to determine the risk factors and clinical outcomes of hvKP-BSIs in populations admitted in a teaching hospital of Nanjing, China. The genetic characteristics and antibiotic resistance patterns of the hvKP strains were further analyzed. A retrospective study was conducted in 143 patients with K. pneumoniae BSIs at Jinling Hospital in China from September 2015 to December 2016. A positive polymerase chain reaction (PCR) amplification of the plasmid-borne rmpA (p-rmpA) and aerobactin (iucA) was identified as hvKP. Overall, 24.5% (35/143) of K. pneumoniae isolates were hvKP. Multivariate analysis implicated diabetes mellitus (OR = 3.356) and community-acquired BSIs (OR = 4.898) as independent risk factors for hvKP-BSIs. The 30-day mortality rate of the hvKP-BSIs group was 37.1% (13/35) compared with 40.7% (44/108) in the cKP-BSIs control group (P = 0.706). The KPC-producing isolates (OR = 2.851), underlying disease with gastrointestinal fistula (OR = 3.054), APACHE II score ≥ 15 (OR = 6.694) and Pitt bacteremia score ≥ 2 (OR = 6.232) at infection onset were independent predictors for 30-day mortality of K. pneumoniae bacteremia patients. A high percentage (57.1%, 20/35) of KPC-producing isolates was observed among hvKP strains and ST11 was dominant in hvKP strains (17/35, 48.6%). KPC-producing hvKP is emerging, indicating the importance of epidemiologic surveillance and clinical awareness of this pathogen.

Entities:  

Keywords:  Bloodstream infections; Hypervirulent Klebsiella pneumoniae; Klebsiella pneumoniae Carbapenemase; Molecular characteristics; Mortality; Risk factors

Mesh:

Substances:

Year:  2017        PMID: 29238932     DOI: 10.1007/s10096-017-3160-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  39 in total

Review 1.  Hypervirulence and hypermucoviscosity: Two different but complementary Klebsiella spp. phenotypes?

Authors:  Juan Carlos Catalán-Nájera; Ulises Garza-Ramos; Humberto Barrios-Camacho
Journal:  Virulence       Date:  2017-04-12       Impact factor: 5.882

2.  Infections caused by KPC-producing Klebsiella pneumoniae: differences in therapy and mortality in a multicentre study.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Francesco Giuseppe De Rosa; Maddalena Giannella; Daniele Roberto Giacobbe; Matteo Bassetti; Angela Raffaella Losito; Michele Bartoletti; Valerio Del Bono; Silvia Corcione; Giuseppe Maiuro; Sara Tedeschi; Luigi Celani; Chiara Simona Cardellino; Teresa Spanu; Anna Marchese; Simone Ambretti; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  J Antimicrob Chemother       Date:  2015-04-21       Impact factor: 5.790

3.  Influence of the bacterial phenotypes on the clinical manifestations in Klebsiella pneumoniae bacteremia patients: A retrospective cohort study.

Authors:  Atsushi Togawa; Hiromi Toh; Kyoko Onozawa; Michinobu Yoshimura; Chiemi Tokushige; Nobuyuki Shimono; Tohru Takata; Kazuo Tamura
Journal:  J Infect Chemother       Date:  2015-04-22       Impact factor: 2.211

4.  Clinical and phenotypic differences between classic and hypervirulent Klebsiella pneumonia: an emerging and under-recognized pathogenic variant.

Authors:  D K Pomakova; C-B Hsiao; J M Beanan; R Olson; U MacDonald; Y Keynan; T A Russo
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2011-09-15       Impact factor: 3.267

Review 5.  Primary osteomyelitis caused by hypervirulent Klebsiella pneumoniae.

Authors:  Bonnie C Prokesch; Michael TeKippe; Jiwoong Kim; Prithvi Raj; Erin McElvania TeKippe; David E Greenberg
Journal:  Lancet Infect Dis       Date:  2016-07-09       Impact factor: 25.071

6.  Molecular epidemiology and virulence factors of pyogenic liver abscess causing Klebsiella pneumoniae in China.

Authors:  Y Luo; Y Wang; L Ye; J Yang
Journal:  Clin Microbiol Infect       Date:  2014-06-14       Impact factor: 8.067

7.  Aerobactin, but not yersiniabactin, salmochelin, or enterobactin, enables the growth/survival of hypervirulent (hypermucoviscous) Klebsiella pneumoniae ex vivo and in vivo.

Authors:  Thomas A Russo; Ruth Olson; Ulrike MacDonald; Janet Beanan; Bruce A Davidson
Journal:  Infect Immun       Date:  2015-06-08       Impact factor: 3.441

8.  A novel PCR-based genotyping scheme for clinical Klebsiella pneumoniae.

Authors:  Zhenhong Chen; Mengying Liu; Yujun Cui; Li Wang; Yiquan Zhang; Jingfu Qiu; Ruifu Yang; Changting Liu; Dongsheng Zhou
Journal:  Future Microbiol       Date:  2014       Impact factor: 3.165

9.  Evolution and Transmission of Carbapenem-Resistant Klebsiella pneumoniae Expressing the blaOXA-232 Gene During an Institutional Outbreak Associated With Endoscopic Retrograde Cholangiopancreatography.

Authors:  Shangxin Yang; Peera Hemarajata; Janet Hindler; Fan Li; Helty Adisetiyo; Grace Aldrovandi; Robert Sebra; Andrew Kasarskis; Duncan MacCannell; Xavier Didelot; Dana Russell; Zachary Rubin; Romney Humphries
Journal:  Clin Infect Dis       Date:  2017-04-01       Impact factor: 9.079

10.  Plasmid transferability of KPC into a virulent K2 serotype Klebsiella pneumoniae.

Authors:  Leung-Kei Kristopher Siu; David B Huang; Tom Chiang
Journal:  BMC Infect Dis       Date:  2014-03-31       Impact factor: 3.090

View more
  27 in total

1.  Clinical and virulence factors related to the 30-day mortality of Klebsiella pneumoniae bacteremia at a tertiary hospital: a case-control study.

Authors:  Hiroki Namikawa; Makoto Niki; Mamiko Niki; Koichi Yamada; Kiyotaka Nakaie; Arata Sakiyama; Ken-Ichi Oinuma; Taishi Tsubouchi; Yoshihiro Tochino; Yasuhiko Takemoto; Yukihiro Kaneko; Taichi Shuto; Hiroshi Kakeya
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-10-11       Impact factor: 3.267

2.  Clonal spread of carbapenemase-producing Enterobacteriaceae in a region, China.

Authors:  Changfu Yin; Weiwei Yang; Yuanpeng Lv; Peng Zhao; Jiansheng Wang
Journal:  BMC Microbiol       Date:  2022-03-29       Impact factor: 3.605

3.  The Anti-Virulence Effect of Sub-Minimal Inhibitory Concentrations of Levofloxacin on Hypervirulent Klebsiella pneumoniae.

Authors:  Xuejiao Ma; Li Zhang; Chengcheng Yue; YanYan Liu; Jiabin Li
Journal:  Infect Drug Resist       Date:  2022-07-04       Impact factor: 4.177

4.  Development of risk factor-based scoring system for detection of hypervirulent Klebsiella pneumoniae bloodstream infections.

Authors:  Michinobu Yoshimura; Chiemi Tokushige; Atsushi Togawa; Akira Matsunaga; Tohru Takata; Yasushi Takamatsu
Journal:  Gut Pathog       Date:  2020-07-09       Impact factor: 4.181

5.  Molecular epidemiology of virulence and antimicrobial resistance determinants in Klebsiella pneumoniae from hospitalised patients in Kilimanjaro, Tanzania.

Authors:  Tolbert Sonda; Happiness Kumburu; Marco van Zwetselaar; Michael Alifrangis; Blandina T Mmbaga; Ole Lund; Gibson S Kibiki; Frank M Aarestrup
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-07-20       Impact factor: 3.267

Review 6.  Hypervirulent Klebsiella pneumoniae - clinical and molecular perspectives.

Authors:  J E Choby; J Howard-Anderson; D S Weiss
Journal:  J Intern Med       Date:  2019-11-21       Impact factor: 8.989

7.  Case Report of Primary Lung Abscesses Due to Hypervirulent Klebsiella pneumoniae (Serotype K2, Sequence Type 375): an Emerging Isolate in Okinawa, Japan.

Authors:  Jun Hirai; Daisuke Sakanashi; Masashi Momose; Tomomi Koga; Takeshi Kinjo; Shusaku Haranaga; Eiji Motonaga; Jiro Fujita
Journal:  Infect Drug Resist       Date:  2020-06-10       Impact factor: 4.003

8.  Virulence and genomic features of a bla CTX-M-3 and bla CTX-M-14 coharboring hypermucoviscous Klebsiella pneumoniae of serotype K2 and ST65.

Authors:  Yiqi Fu; Min Xu; Yanchao Liu; Ang Li; Jianying Zhou
Journal:  Infect Drug Resist       Date:  2019-01-03       Impact factor: 4.003

9.  Antibiotic-resistant hypervirulent Klebsiella pneumoniae causing community- acquired liver abscess: an emerging disease.

Authors:  S Rodriguez-Villar; A Fife; C Baldwin; R R Warne
Journal:  Oxf Med Case Reports       Date:  2019-05-31

10.  Rapid identification of capsular serotype K1/K2 Klebsiella pneumoniae in pus samples from liver abscess patients and positive blood culture samples from bacteremia cases via an immunochromatographic strip assay.

Authors:  Ching-Hsun Wang; Po-Liang Lu; Esther Yip-Mei Liu; Yih-Yuan Chen; Fu-Mei Lin; Yi-Tsung Lin; Feng-Yee Chang; Jung-Chung Lin
Journal:  Gut Pathog       Date:  2019-02-22       Impact factor: 4.181

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.